antimony has been researched along with Carcinoma, Ductal, Breast in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agarwal, G; Gambhir, S; Krishnani, N; Mayilvaganan, S; Mishra, A; Rajan, S | 1 |
1 trial(s) available for antimony and Carcinoma, Ductal, Breast
| Article | Year |
|---|---|
Prospective Randomized Trial of Use of In-House Prepared Low-Cost Radiopharmaceutical Versus Commercial Radiopharmaceutical for Sentinel Lymph Node Biopsy in Patients with Early Stage Invasive Breast Cancer.
Topics: Antimony; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Humans; Indicators and Reagents; Methylene Blue; Middle Aged; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Sentinel Lymph Node Biopsy; Sulfur; Technetium Compounds | 2018 |